Literature DB >> 16570352

Effect of 5-HT1 agonist (sumatriptan) on anorectal function in irritable bowel syndrome patients.

Agata Mulak1, Leszek Paradowski.   

Abstract

AIM: To evaluate the effect of sumatriptan, a selective 5-HT1 agonist, on anorectal function in irritable bowel syndrome (IBS) patients.
METHODS: Twenty-two IBS patients selected according to the Rome II criteria (F 15, M 7; mean age 29.3+/-6.8, range 22-44 years) were examined. The study was blind, randomized and placebo-controlled with a crossover design. Anorectal manometry and rectal balloon distension test were performed before and after the administration of placebo and sumatriptan.
RESULTS: The administration of sumatriptan caused a significant increase in the resting anal canal pressure from 9.2+/-2.0 kPa to 13.1+/-3.3 kPa (P<0.0001) connected with the increase in the anal sphincter length and high pressure zone. After sumatriptan injection a remarkable increase in the threshold for the first sensation from 27+/-9 mL to 34+/-12 mL (P<0.05) and urge sensation from 61+/-19 mL to 68+/-18 mL (P<0.01) was observed. Sumatriptan did not affect either the volume evoking the rectoanal inhibitory reflex or the results of the straining test.
CONCLUSION: 5-HT1 receptors participate in the regulation of anorectal function. Elucidation of the role of 5-HT1 receptors in the pathophysiological mechanisms of IBS may have some therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570352      PMCID: PMC4124292          DOI: 10.3748/wjg.v12.i10.1591

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

Review 1.  Serotonin: a mediator of the brain-gut connection.

Authors:  D Y Kim; M Camilleri
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

2.  Effect of the 5-HT1 agonist sumatriptan on oesophageal motor pattern in patients with ineffective oesophageal motility.

Authors:  L Grossi; A F Ciccaglione; L Marzio
Journal:  Neurogastroenterol Motil       Date:  2003-02       Impact factor: 3.598

Review 3.  Serotoninergic neuroenteric modulators.

Authors:  N J Talley
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

4.  The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers.

Authors:  L A Houghton; R Lea; N Jackson; P J Whorwell
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 5.  Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Authors:  William E Whitehead; Olafur Palsson; Kenneth R Jones
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

Review 6.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man.

Authors:  J Tack; B Coulie; A Wilmer; A Andrioli; J Janssens
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

8.  Effect of intranasal sumatriptan on gastric tone and sensitivity to distension.

Authors:  G Sarnelli; J Janssens; J Tack
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

9.  An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.

Authors:  M Simrén; H Abrahamsson; E S Björnsson
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

10.  Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.

Authors:  C E J Sloots; A C Poen; R Kerstens; M Stevens; M De Pauw; J C Van Oene; S G M Meuwissen; R J F Felt-Bersma
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

View more
  3 in total

Review 1.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

2.  Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan.

Authors:  Louis P Vera-Portocarrero; Michael H Ossipov; Tamara King; Frank Porreca
Journal:  Gastroenterology       Date:  2008-07-03       Impact factor: 22.682

3.  Brain-Gut Interactions in IBS.

Authors:  Jakub Fichna; Martin A Storr
Journal:  Front Pharmacol       Date:  2012-07-05       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.